Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2021-2026

  • receipt Report ID : 260969
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of 23-Valent Pneumococcal Polysaccharide Vaccine will have significant change from previous year. By the most conservative estimates of global 23-Valent Pneumococcal Polysaccharide Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2326.5 million in 2020. Over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 14.9% CAGR in terms of revenue, the global market size will reach US$ 4060.3 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Single Dose Vial

Pre-filled Syringe

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

For Children (2-10)

For Person (10-64)

For The Old (≥65)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

MSD

Sanofipasteur

CDIBP

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2016-2026

2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region

2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type

2.2.1 Single Dose Vial

2.2.2 Pre-filled Syringe

2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2016-2021)

2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application

2.4.1 For Children (2-10)

2.4.2 For Person (10-64)

2.4.3 For The Old (≥65)

2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2016-2021)

3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company

3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company

3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2021)

3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2021)

3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company

3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2021)

3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company

3.4 Global Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution

3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 23-Valent Pneumococcal Polysaccharide Vaccine by Region

4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Region

4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region

4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region

4.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth

4.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth

4.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth

4.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth

5 Americas

5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country

5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)

5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)

5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region

6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021)

6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021)

6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country

7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)

7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)

7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country

8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type

8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors

10.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer

11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast

11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region

11.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions (2021-2026)

11.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type

11.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application

12 Key Players Analysis

12.1 MSD

12.1.1 MSD Company Information

12.1.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered

12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 MSD Main Business Overview

12.1.5 MSD Latest Developments

12.2 Sanofipasteur

12.2.1 Sanofipasteur Company Information

12.2.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered

12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Sanofipasteur Main Business Overview

12.2.5 Sanofipasteur Latest Developments

12.3 CDIBP

12.3.1 CDIBP Company Information

12.3.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered

12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 CDIBP Main Business Overview

12.3.5 CDIBP Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Single Dose Vial

Table 3. Major Players of Pre-filled Syringe

Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)

Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)

Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & ($ million)

Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)

Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2016-2021)

Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)

Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)

Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Application (2016-2021)

Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)

Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2016-2021)

Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2021) & (K Dose)

Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2021)

Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2021)

Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2019-2021)

Table 19. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area

Table 20. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered

Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) (K Dose)

Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)

Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)

Table 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)

Table 29. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)

Table 30. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)

Table 32. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)

Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)

Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)

Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)

Table 36. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)

Table 37. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)

Table 38. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)

Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)

Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)

Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)

Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)

Table 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)

Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)

Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)

Table 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)

Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)

Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)

Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)

Table 53. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)

Table 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)

Table 59. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of 23-Valent Pneumococcal Polysaccharide Vaccine

Table 61. Key Application and Potential Industries of 23-Valent Pneumococcal Polysaccharide Vaccine

Table 62. Key Challenges of 23-Valent Pneumococcal Polysaccharide Vaccine

Table 63. Key Trends of 23-Valent Pneumococcal Polysaccharide Vaccine

Table 64. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List

Table 65. 23-Valent Pneumococcal Polysaccharide Vaccine Customer List

Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2021-2026) & (K Dose)

Table 67. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Forecast by Region

Table 68. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2021-2026) & (K Dose)

Table 71. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Region (2021-2026) & (K Dose)

Table 73. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2021-2026) & (K Dose)

Table 75. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2021-2026) & (K Dose)

Table 77. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026) & (K Dose)

Table 79. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 80. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026) & (K Dose)

Table 83. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 84. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 86. MSD Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 87. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered

Table 88. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 89. MSD Main Business

Table 90. MSD Latest Developments

Table 91. Sanofipasteur Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 92. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered

Table 93. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 94. Sanofipasteur Main Business

Table 95. Sanofipasteur Latest Developments

Table 96. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 97. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered

Table 98. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 99. CDIBP Main Business

Table 100. CDIBP Latest Developments

List of Figures

Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine

Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2026 (K Dose)

Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Single Dose Vial

Figure 10. Product Picture of Pre-filled Syringe

Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020

Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)

Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)

Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2016-2021) & (K Dose)

Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)

Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2016-2021) & (K Dose)

Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (≥65)

Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (≥65) (2016-2021) & (K Dose)

Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)

Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2020

Figure 21. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2020

Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2016-2021)

Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020

Figure 25. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)

Figure 26. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)

Figure 27. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)

Figure 28. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)

Figure 29. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)

Figure 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)

Figure 32. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)

Figure 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020

Figure 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020

Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020

Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020

Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020

Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2020

Figure 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020

Figure 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020

Figure 45. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020

Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020

Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020

Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020

Figure 55. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020

Figure 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020

Figure 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020

Figure 64. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Please fill the form below, to recieve the report sample


+1